Capecitabine in ER+/HER2-negative Breast Cancer

NCT07631052 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

ER-positive, HER2-negative Breast Cancer
Breast Cancer Stage I
Breast Cancer Stage II
Breast Cancer Stage III

Interventions

DRUG: Capecitabine

Sponsor

University Health Network, Toronto